Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study

BACKGROUND: Few data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens in patients with left-sided RAS/BRAF wild-type metastatic colorectal cancer (mCRC) are available. METHODS: This multicenter, retrospective study aimed at...

Descripción completa

Detalles Bibliográficos
Autores principales: Parisi, Alessandro, Cortellini, Alessio, Venditti, Olga, Filippi, Roberto, Salvatore, Lisa, Tortora, Giampaolo, Ghidini, Michele, Nigro, Olga, Gelsomino, Fabio, Zurlo, Ina Valeria, Fulgenzi, Claudia, Lombardi, Pasquale, Roselló Keränen, Susana, Depetris, Ilaria, Giampieri, Riccardo, Morelli, Cristina, Di Marino, Pietro, Di Pietro, Francesca Romana, Zanaletti, Nicoletta, Vitale, Pasquale, Garajova, Ingrid, Spinelli, Gian Paolo, Zoratto, Federica, Roberto, Michela, Petrillo, Angelica, Aimar, Giacomo, Patruno, Leonardo, D’Orazio, Carla, Ficorella, Corrado, Ferri, Claudio, Porzio, Giampiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579084/
https://www.ncbi.nlm.nih.gov/pubmed/34778029
http://dx.doi.org/10.3389/fonc.2021.712053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579084/
https://www.ncbi.nlm.nih.gov/pubmed/34778029
http://dx.doi.org/10.3389/fonc.2021.712053

Ejemplares similares